Monopar Therapeutics - 54 Year Dividend History | MNPR
Historical dividend payout and yield for Monopar Therapeutics (MNPR) since 1971. The current TTM dividend payout for Monopar Therapeutics (MNPR) as of January 13, 2025 is $0.00. The current dividend yield for Monopar Therapeutics as of January 13, 2025 is 0.00%.
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$0.134B |
$0.000B |
Monopar Therapeutics Inc. is a biopharmaceutical company. It is focused on developing drugs for cancer patients. The company's intellectual property pipeline consists of Validive(R), Camsirubicin (MNPR-201) and MNPR-101 which are in clinical stage. Monopar Therapeutics Inc. is based in Wilmette, United States.
|
Stock Name |
Country |
Market Cap |
PE Ratio |